Company Filing History:
1 out of 314 
1 out of 140 
1 out of 9 
Years Active: 2012
Title: Yasuji Ueda - Innovator in Cancer Treatment
Introduction
Yasuji Ueda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Ueda holds a patent for a method of treating cancer with an RPN2 gene expression inhibitor. This invention utilizes an RPN2 gene expression inhibitor as a cancer cell growth inhibitor. It can also include a drug that exhibits anti-cancer action and may be administered in combination with atelocollagen if desired. Furthermore, the invention encompasses an anti-cancer agent that includes such a cancer cell growth inhibitor.
Career Highlights
Throughout his career, Ueda has worked with prominent companies in the pharmaceutical industry, including Taisho Pharmaceutical Co., Ltd. and Dainippon Sumitomo Pharma Co., Ltd. His work has focused on developing effective treatments for cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Ueda has collaborated with esteemed colleagues such as Takahiro Ochiya and Kikuya Kato. These partnerships have contributed to the advancement of his research and the development of innovative cancer treatments.
Conclusion
Yasuji Ueda's contributions to cancer treatment through his patented methods and collaborations highlight his role as a significant innovator in the field. His work continues to inspire advancements in medical research and treatment options for cancer patients.